The Associated Press
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years. “Five years after the initial accelerated approval, you should have a definitive answer,” said Dr.
Of those, 63% were converted to regular approval even though only 43% demonstrated a clinical benefit in confirmatory trials. The research was published in the Journal of the American Medical Association and discussed at the American Association for Cancer Research annual meeting in San Diego on Sunday. It’s unclear how much cancer patients understand about drugs with accelerated approval, said study co-author Dr. Edward Cliff of Harvard Medical School.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Associated Press Debunks Its Own Smear of Trump-Backed Bernie Moreno Days Before Ohio ElectionSource of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Read more »
Exclusive — Associated Press Admits It Has No ‘Geolocation Data’ to Back Up Bernie Moreno SmearSource of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Read more »
Associated Press Under Fire as Senators, Lawyers Question Legal Liability After Moreno Attack PieceSource of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Read more »
The Associated Press 2023-24 men's college basketball All-America teamsPurdue big man Zach Edey headlined the 2023-24 men's college basketball teams for The Associated Press on Tuesday. Edey was an unanimous first-team pick choice for the second straight season. Edey was joined on the first team by Tennessee's Dalton Knecht, North Carolina's RJ Davis, Houston's Jamal Shead and Connecticut's Tristen Newton.
Read more »
No more AP: Gannett, McClatchy news chains say they will stop using Associated Press contentThe Gannett and McClatchy news chains, publishers of more than 230 outlets including USA Today and the Miami Herald, have said they will stop using journalism from The Associated Press amid continued financial pressures for the news industry.
Read more »
T-Squared: Associated Press, Texas Tribune to share select news content in new collaborationAP will distribute Tribune articles to its members. The Tribune will have access to AP’s immigration and Texas stories.
Read more »